Table 10.
Criteria and classification of TACE-unsuitable
| TACE-unsuitability is defined as each one of the following 3 clinical conditions that prevent a survival benefit from TACE or conditions that TACE is even harmful: | |||||
| 1 | Likely to develop TACE failure/refractoriness: | ||||
| Up-to-7 criteria out nodules | |||||
| 2 | Likely to become Child-Pugh B liver function after TACE: | ||||
| Up-to-7 criteria out nodules (especially, bilobar multifocal nodules), mALBI grade 2b | |||||
| 3 | Unlikely to respond to TACE: | ||||
| Confluent multinodular type, massive or infiltrative type, simple nodular type with extranodular growth, poorly differentiated type, intrahepatic multiple disseminated nodules, or sarcomatous changes after TACE | |||||
TACE, transarterial chemoembolization; mALBI, modified albumin-bilirubin.